|
|
Gene Symbol |
MIR16-2 |
|
Aliases |
MIRN16-2, mir-16-2, mir-16-3 |
|
Entrez Gene ID |
|
|
Gene Name |
MicroRNA 16-2 |
|
Chromosomal Location |
3q25.33 |
|
HGNC ID |
|
|
Summary |
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001937 |
Biological process |
Negative regulation of endothelial cell proliferation |
IDA |
21885851 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IGI |
22139073 |
GO:0016525 |
Biological process |
Negative regulation of angiogenesis |
IDA |
21885851, 23233752 |
GO:0032088 |
Biological process |
Negative regulation of NF-kappaB transcription factor activity |
IDA |
30365148 |
GO:0035195 |
Biological process |
Gene silencing by miRNA |
IDA |
15131085, 16166262, 18449891, 19823025, 21532615, 21885851, 22139073, 23487264, 25033200, 25261849, 25594541, 25743273, 27343180, 27748453 |
GO:0035278 |
Biological process |
MiRNA mediated inhibition of translation |
IDA |
23233752 |
GO:0035278 |
Biological process |
MiRNA mediated inhibition of translation |
IGI |
25403480 |
GO:0040037 |
Biological process |
Negative regulation of fibroblast growth factor receptor signaling pathway |
IDA |
21885851 |
GO:0043065 |
Biological process |
Positive regulation of apoptotic process |
IDA |
25261849 |
GO:0043124 |
Biological process |
Negative regulation of I-kappaB kinase/NF-kappaB signaling |
IDA |
23487264 |
GO:0045727 |
Biological process |
Positive regulation of translation |
IGI |
25403480 |
GO:0050728 |
Biological process |
Negative regulation of inflammatory response |
IDA |
30365148 |
GO:0071333 |
Biological process |
Cellular response to glucose stimulus |
IDA |
30365148 |
GO:0090051 |
Biological process |
Negative regulation of cell migration involved in sprouting angiogenesis |
IDA |
27748453 |
GO:0110081 |
Biological process |
Negative regulation of placenta blood vessel development |
IDA |
27748453 |
GO:1900747 |
Biological process |
Negative regulation of vascular endothelial growth factor signaling pathway |
IDA |
21885851 |
GO:1903588 |
Biological process |
Negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
IDA |
21885851, 27748453 |
GO:1904848 |
Biological process |
Negative regulation of cell chemotaxis to fibroblast growth factor |
IDA |
23233752 |
GO:1904858 |
Biological process |
Negative regulation of endothelial cell chemotaxis to vascular endothelial growth factor |
IDA |
21885851 |
GO:2000134 |
Biological process |
Negative regulation of G1/S transition of mitotic cell cycle |
IDA |
25261849 |
GO:2000134 |
Biological process |
Negative regulation of G1/S transition of mitotic cell cycle |
IGI |
21454377 |
GO:2000545 |
Biological process |
Negative regulation of endothelial cell chemotaxis to fibroblast growth factor |
IDA |
21885851 |
GO:2001244 |
Biological process |
Positive regulation of intrinsic apoptotic signaling pathway |
IGI |
16166262 |
GO:0005615 |
Cellular component |
Extracellular space |
HDA |
18766170, 26646931 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
20159880 |
GO:0070062 |
Cellular component |
Extracellular exosome |
IDA |
23233752, 28159509 |
GO:0000993 |
Molecular function |
RNA polymerase II complex binding |
IDA |
25336585 |
GO:1903231 |
Molecular function |
MRNA binding involved in posttranscriptional gene silencing |
IDA |
15131085, 16166262, 18449891, 19823025, 21532615, 21885851, 22139073, 23233752, 25033200, 25261849, 25594541, 25743273, 27343180, 27748453 |
|
|
|
|
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Polycythemia vera |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
PDCD4, eIF4A |
PCOS, amenorrhea, abnormal folliculogenesis, chronic anovulation, hyperandrogenemia, infertility, insulin resistance, obesity, dyslipidemia, hypertension, pancreatic ?-cell dysfunction, increasing the risk of type 2 diabetes mellitus (T2DM), and cardiovas |
|
Rotterdam 2003 criteria |
Related
|
19 PCOS women and 19 control women |
miR-16 promoted ovarian GCs proliferation and inhibited apoptosis through directly targeting PDCD4 in PCOS, contributing to a better understanding of the molecular mechanism of GCs dysregulation and providing a promising target in PCOS. |
|
|
|
|